MedPath

Study on Fatty Liver Disease comparing the intervention with Cauterization and Blood letting therapy

Phase 2
Completed
Conditions
Inflammatory liver disease, unspecified. Ayurveda Condition: YAKRUDDALYUDARAH,
Registration Number
CTRI/2023/11/059678
Lead Sponsor
Dr Megha R
Brief Summary

**A comparative clinical study to evaluate the efficacy of Agnikarma and Siravyadha in yakkriddaludara vis-a-vis fatty liver disease.**

Subjects fulfilling subjective and objective criterias will be choosen for the study, one group consisting of 20 subjects will be treated with Agnikarma at dakshina manibandha (right anatomical snuff box) another group of 20 subjects will be treated with siravyadha at dakshina kurpara sandhi(right cubital region) for 4 sitting each with a gap of 7 days and follow up will be done after 45 days of first sitting.

After completion of the treatment, Group B that is the subjects treated with Siravyadha showed better result.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
40
Inclusion Criteria

Sonologically diagnosed case of grade 1 and grade 2 fatty liver disease.

Exclusion Criteria

Uncontrolled DM and HTN, suffering with other systemic disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in ultra sonography reading and SGOT, SGPT level, Weight, reduce in Klama, Adhmana, agnimandya and hritkanta daha after 15 days of completion of 4th sitting of the procedureAt baseline, 1st week, 2nd week, 3rd week, 4th week and 6th week
Secondary Outcome Measures
NameTimeMethod
Objective criterias like USG, SGOT SGOT, WeightAt base line & After 15 days of completion of treatment i.e., on 6 weeks

Trial Locations

Locations (1)

Ayurveda Mahavidyalaya and Hospital, Hubballi

🇮🇳

Dharwad, KARNATAKA, India

Ayurveda Mahavidyalaya and Hospital, Hubballi
🇮🇳Dharwad, KARNATAKA, India
Dr Megha R
Principal investigator
8951176641
lodgaaasrvms@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.